News

The new product is incorporated in the company’s proprietary delivery system which allows the peptides to penetrate the skin and be delivered to the desired layers, making it

GE featured remote access to its portfolio of electronic medical records (EMRs) for physician practices, including Centricity Advance and Centricity Practice Solution, on the Apple iPad and iPhone.

Discovered by Takeda, the compound is indicated for the treatment of hypertension, or high blood pressure. Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) which lowers blood

euSEND brings together universities, pharma firms, other international research organizations and product development partnerships to encourage development of solutions for neglected tropical diseases. The Dutch initiative builds, amongst

The renal study evaluated the safety and efficacy of Onglyza in patients with moderate to severe renal impairment or end-stage renal disease (ESRD). The 12-week data revealed that

The DSMB concluded that the studies may continue without protocol modification, and that no other formal meetings of the DSMB are needed. The DSMB reviewed safety data from

The approval includes two additional Agilent Microarray scanners and two Agilent Bioanalyzers, increasing aboratory capacity to handle the increasing number of MammaPrint, TargetPrint and BluePrint test requests. The

Votrient is a targeted oral treatment, which is an effective first-line treatment for advanced renal cell carcinoma (as acknowledged by NICE) since it slows down progression of the

The last patient has been treated with the company’s proprietary photosensitiser Amphinex used in combination with the cytotoxic agent bleomycin at University College Hospital (UCH) in London. Principal